GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Foreign Relations FOR

Issues related to access to pharmaceuticals, international finance for health services and intellectual property protection.

Contacted: Commerce, Dept of (DOC); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); State, Dept of (DOS); Veterans Affairs, Dept of (VA); Defense, Dept of (DOD); Office of Management & Budget (OMB)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; HIV policy issues, HCV issues, patent reform

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Commerce, Dept of (DOC); SENATE; Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Defense, Dept of (DOD); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Defense DEF

Education related to HCV issues.

Contacted: Defense, Dept of (DOD); Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA); State, Dept of (DOS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Office of Management & Budget (OMB)

Veterans VET

Appropriations; education related to Hepatitis C. Access to Care Act, HR 4810. Issues related to coverage, access and reimbursement of pharmaceuticals for veterans.

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; Defense, Dept of (DOD); Veterans Affairs, Dept of (VA); State, Dept of (DOS); Commerce, Dept of (DOC)

Bills named: H.R. 4810 (114th)

Health Issues HCR

Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization, Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs.

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Defense, Dept of (DOD); Veterans Affairs, Dept of (VA); SENATE; State, Dept of (DOS); Office of Management & Budget (OMB)

Medicare/Medicaid MMM

Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products. Viral Hepatitis Testing, Screening and treatment;HIV Testing, Research and Treatment; Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act;Issues related to coverage and reimbursement of pharmaceuticals; and FDA issues and 340B.

Contacted: Health & Human Services, Dept of (HHS); SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Commerce, Dept of (DOC); Defense, Dept of (DOD); Office of Management & Budget (OMB)

Pharmacy PHA

Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; Issues related to coverage and reimbursement of pharmaceuticals; Issues related to Medicare, Medicaid and Affordable Care Act implementation; and FDA issues and 340B.

Contacted: Office of Management & Budget (OMB); Veterans Affairs, Dept of (VA); SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Commerce, Dept of (DOC); Defense, Dept of (DOD); State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Issues related to healthcare funding and cost-savings.

Contacted: Commerce, Dept of (DOC); Defense, Dept of (DOD); Office of Management & Budget (OMB); Veterans Affairs, Dept of (VA); State, Dept of (DOS); Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Specific lobbying issues: HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation.Issues related to access to pharmaceuticals and intellectual property protection.

Contacted: Office of Management & Budget (OMB); Executive Office of the President (EOP); Defense, Dept of (DOD); SENATE; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); State, Dept of (DOS)

Science/Technology SCI

Issues related to pharmaceutical innovation and intellectual property protection.

Contacted: Office of Management & Budget (OMB); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); Executive Office of the President (EOP)